Table 1 Range of treatment plans on issues.
From: Deep deterministic policy gradient-based automatic negotiation framework for shared decision-making
Treatments | Issue | ||||
|---|---|---|---|---|---|
| Â | Cost | Effectiveness | Side-effects | Risk | Convenience |
En-High Dose ICS/LABAa | 2.9-4.5 | 8-8 | 1-2 | 10-20 | 10-10 |
En-High Dose ICSb + LTRAc | 3.7-5.3 | 7-7 | 3-5 | 15-25 | 9-9 |
En-High Dose ICS + Sustained-Release THPd | 2.1-5.1 | 6-7 | 10-15 | 20-25 | 8-8 |
En-High Dose ICS/LABA + LTRA | 5.8-7.4 | 9-10 | 8-10 | 5-10 | 7.5-8 |
En-High Dose ICS/LABA + Sustained-Release THP | 4.2-7.2 | 9-10 | 10-12 | 5-10 | 7.5-8 |
